Page last updated: 2024-11-06

floxuridine and B16 Melanoma

floxuridine has been researched along with B16 Melanoma in 2 studies

Floxuridine: An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection; when administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.
floxuridine : A pyrimidine 2'-deoxyribonucleoside compound having 5-fluorouracil as the nucleobase; used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fries, KM1
Joswig, C1
Borch, RF1
FitzGerald, GB1
Wick, MM1

Other Studies

2 other studies available for floxuridine and B16 Melanoma

ArticleYear
Synthesis and biological evaluation of 5-fluoro-2'-deoxyuridine phosphoramidate analogs.
    Journal of medicinal chemistry, 1995, Jul-07, Volume: 38, Issue:14

    Topics: Amides; Animals; Antineoplastic Agents; Floxuridine; Leukemia L1210; Magnetic Resonance Spectroscopy

1995
Comparison of the inhibitory effects of hydroxyurea, 5-fluorodeoxyuridine, 3,4-dihydroxybenzylamine, and methotrexate on human squamous cell carcinoma.
    The Journal of investigative dermatology, 1987, Volume: 88, Issue:1

    Topics: Animals; Carcinoma, Squamous Cell; Cell Line; Deoxyuracil Nucleotides; Depression, Chemical; DNA Rep

1987